share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Nov 5 20:05

Gainers

  • Bionomics (NASDAQ:BNOX) shares moved upwards by 115.4% to $0.41 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.4 million.
  • Cocrystal Pharma (NASDAQ:COCP) shares increased by 12.37% to $2.09. The company's market cap stands at $21.2 million.
  • QT Imaging Holdings (NASDAQ:QTI) stock moved upwards by 12.09% to $0.66. The market value of their outstanding shares is at $14.1 million.
  • Cyclerion Therapeutics (NASDAQ:CYCN) stock increased by 10.38% to $2.91. The market value of their outstanding shares is at $7.3 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares increased by 9.73% to $0.08. The company's market cap stands at $1.3 million.
  • Hims & Hers Health (NYSE:HIMS) stock moved upwards by 8.86% to $22.6. The company's market cap stands at $4.8 billion. The company's, Q3 earnings came out yesterday.

Losers

  • Verrica Pharmaceuticals (NASDAQ:VRCA) stock declined by 32.2% to $0.97 during Tuesday's pre-market session. The company's market cap stands at $41.3 million. As per the press release, Q3 earnings came out yesterday.
  • Tactile Systems Tech (NASDAQ:TCMD) shares declined by 14.43% to $12.93. The company's market cap stands at $309.8 million. The company's, Q3 earnings came out yesterday.
  • Apellis Pharmaceuticals (NASDAQ:APLS) stock declined by 11.77% to $25.2. The market value of their outstanding shares is at $3.0 billion. As per the press release, Q3 earnings came out today.
  • Theriva Biologics (AMEX:TOVX) shares fell 10.63% to $1.85. The company's market cap stands at $2.5 million.
  • Lixte Biotechnology (NASDAQ:LIXT) shares decreased by 10.26% to $1.75. The market value of their outstanding shares is at $3.9 million.
  • Silexion Therapeutics (NASDAQ:SLXN) shares declined by 8.51% to $0.23. The company's market cap stands at $3.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment